Cytolytic replication of echoviruses in colon cancer cell lines

Virology Journal

Volumn 8, Issue , 2011, Pages

  Israelsson, Stina ^a   Jonsson, Nina ^a   Gullberg, Maria ^a,b   Lindberg, A Michael ^a  

^a LINNAEUS UNIVERSITY   (Sweden)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

colon cancer; echovirus; enterovirus; oncolytic virus; virotherapy

Indexed keywords

ONCOLYTIC VIRUS;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL STRAIN CACO 2; CELL STRAIN HT29; COLON CANCER; ECHO VIRUS; ECHO VIRUS 12; ECHOVIRUS 15; ECHOVIRUS 17; ECHOVIRUS 26; ECHOVIRUS 29; ECHOVIRUS INFECTION; HUMAN; HUMAN CELL; NONHUMAN; SPHEROID CELL; VIRUS REPLICATION; CELL SURVIVAL; COLORECTAL TUMOR; ENTEROVIRUS; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; ONCOLYTIC VIROTHERAPY; TUMOR CELL LINE;

ECHOVIRUS; ENTEROVIRUS; HUMAN ECHOVIRUS 12; HUMAN ENTEROVIRUS B; PICORNAVIRIDAE;

CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; ENTEROVIRUS B, HUMAN; HUMANS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; VIRUS REPLICATION;

EID: 80054008339     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-473     Document Type: Article

References (53)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. Treatment of colon and rectal cancer. Blumberg D, Ramanathan RK, J Clin Gastroenterol 2002 34 15 26 10.1097/00004836-200201000-00005 11743241 (Pubitemid 34038475)
3. Viral oncolysis. Mullen JT, Tanabe KK, Oncologist 2002 7 106 119 10.1634/theoncologist.7-2-106 11961194 (Pubitemid 34438539)
4. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Liu TC, Galanis E, Kirn D, Nat Clin Pract Oncol 2007 4 101 117 10.1038/ncponc0736 17259931 (Pubitemid 46189539)
5. Development of transcriptionally regulated oncolytic adenoviruses. Ko D, Hawkins L, Yu DC, Oncogene 2005 24 7763 7774 10.1038/sj.onc.1209048 16299536 (Pubitemid 41670678)
6. Oncolytic adenoviruses-selective retargeting to tumor cells. Mathis JM, Stoff-Khalili MA, Curiel DT, Oncogene 2005 24 7775 7791 10.1038/sj.onc.1209044 16299537 (Pubitemid 41670679)
7. Herpes simplex virus 1 (HSV-1) for cancer treatment. Shen Y, Nemunaitis J, Cancer Gene Ther 2006 13 975 992 10.1038/sj.cgt.7700946 16604059 (Pubitemid 44564734)
8. Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Kirn DH, Thorne SH, Nat Rev Cancer 2009 9 64 71 10.1038/nrc2545 19104515
9. Reovirus and tumor oncolysis. Kim M, Chung YH, Johnston RN, J Microbiol 2007 45 187 192 17618222 (Pubitemid 47037750)
10. Newcastle disease virus as an oncolytic agent. Ravindra PV, Tiwari AK, Sharma B, Chauhan RS, Indian J Med Res 2009 130 507 513 20090097
11. Picornaviridae: The viruses and their replication. Racaniello V, Fields Virology Philadelphia: Lippincott Williams and Wilkins, a Wolters Kluwer business, Knipe M, Howley PM, 5 2007 1 795 838
12. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. Pallansch M, Roos R, Fields Virology Philadelphia: Lippincott Williams and Wilkins, a Wolters Kluwer business, Knipe M, Howley PM, 5 2007 1 839 893
13. Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma. Au GG, Lincz LF, Enno A, Shafren DR, Br J Haematol 2007 137 133 141 10.1111/j.1365-2141.2007.06550.x 17391493 (Pubitemid 46474719)
14. Potent oncolytic activity of human enteroviruses against human prostate cancer. Berry LJ, Au GG, Barry RD, Shafren DR, Prostate 2008 68 577 587 10.1002/pros.20741 18288643 (Pubitemid 351614636)
15. Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer. Haley ES, Au GG, Carlton BR, Barry RD, Shafren DR, J Mol Med 2009 87 385 399 10.1007/s00109-008-0433-0 19139835
16. Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21. Shafren DR, Au GG, Nguyen T, Newcombe NG, Haley ES, Beagley L, Johansson ES, Hersey P, Barry RD, Clin Cancer Res 2004 10 53 60 10.1158/1078-0432.CCR-0690-3 14734451 (Pubitemid 38114161)
17. Oncolysis of human ovarian cancers by echovirus type 1. Shafren DR, Sylvester D, Johansson ES, Campbell IG, Barry RD, Int J Cancer 2005 115 320 328 10.1002/ijc.20866 15688406 (Pubitemid 40586744)
18. Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21. Skelding KA, Barry RD, Shafren DR, Breast Cancer Res Treat 2009 113 21 30 10.1007/s10549-008-9899-2 18256929
19. Bovine enterovirus as an oncolytic virus: foetal calf serum facilitates its infection of human cells. Smyth M, Symonds A, Brazinova S, Martin J, Int J Mol Med 2002 10 49 53 12060850
20. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E, Proc Natl Acad Sci USA 2000 97 6803 6808 10.1073/pnas.97.12.6803 10841575 (Pubitemid 30412795)
21. Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus. Ochiai H, Moore SA, Archer GE, Okamura T, Chewning TA, Marks JR, Sampson JH, Gromeier M, Clin Cancer Res 2004 10 4831 4838 10.1158/1078-0432.CCR-03-0694 15269159 (Pubitemid 38955537)
22. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model. Toyoda H, Yin J, Mueller S, Wimmer E, Cello J, Cancer Res 2007 67 2857 2864 10.1158/0008-5472. CAN-06-3713 17363609 (Pubitemid 46548976)
23. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers. Reddy PS, Burroughs KD, Hales LM, Ganesh S, Jones BH, Idamakanti N, Hay C, Li SS, Skele KL, Vasko AJ, Yang J, Watkins DN, Rudin CM, Hallenbeck PL, J Natl Cancer Inst 2007 99 1623 1633 10.1093/jnci/djm198 17971529
24. Treatment of invasive retinoblastoma in a murine model using an oncolytic picornavirus. Wadhwa L, Hurwitz MY, Chevez-Barrios P, Hurwitz RL, Cancer Res 2007 67 10653 10656 10.1158/0008-5472.CAN-07-2352 18006805 (Pubitemid 350145889)
25. Problems raised by certain ECHO viruses in the attempted laboratory detection of poliomyelitis virus infection. Hammon WM, Ludwig EH, Pavia RA, McCloskey LW, Sather GE, Ann N Y Acad Sci 1957 67 304 310 10.1111/j.1749-6632. 1957.tb46054.x 13411968
26. Biologic and serologic characteristics of ECHO viruses from West Virginia. Ormsbee RA, Melnick JL, J Immunol 1957 79 384 392 13491847
27. Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture. Ramos-Alvarez M, Sabin AB, Am J Public Health Nations Health 1956 46 295 299 10.2105/AJPH.46.3.295 13292578
28. Antigenic purity and plaque properties of the prototype strains of ECHO virus types 7 to 11, and 17 and 18. Wigand R, Sabin AB, Arch Gesamte Virusforsch 1962 11 708 717 10.1007/BF01243309 14040255
29. Isolation and characterization of prototype viruses ECHO-26, ECHO-27, Coxsackie B-6. Hammon WM, Yohn DS, Pavia RA, Proc Soc Exp Biol Med 1960 103 164 168 14399342
30. Observations On A Group Of Viruses (Jv-5, Jv-6 And Jv-10) Comprising A Newly Recognized Enterovirus Serotype. Rosen L, Kern J, Bell JA, Am J Hyg 1964 79 7 15 14117623
31. Enterovirus surveillance - United States, 1970-2005. Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, MMWR Surveill Summ 2006 55 1 20 17183230
32. Enteroviruses in Spain over the decade 1998-2007: virological and epidemiological studies. Trallero G, Avellon A, Otero A, De Miguel T, Perez C, Rabella N, Rubio G, Echevarria JE, Cabrerizo M, J Clin Virol 2010 47 170 176 10.1016/j.jcv.2009.11.013 20007023
33. Enteroviruses in Spain: virological and epidemiological studies over 10 years (1988-97). Trallero G, Casas I, Tenorio A, Echevarria JE, Castellanos A, Lozano A, Brena PP, Epidemiol Infect 2000 124 497 506 10.1017/S0950268899003726 10982074 (Pubitemid 30623867)
34. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. Tseng FC, Huang HC, Chi CY, Lin TL, Liu CC, Jian JW, Hsu LC, Wu HS, Yang JY, Chang YW, Wang HC, Hsu YW, Su IJ, Wang JR, J Med Virol 2007 79 1850 1860 10.1002/jmv.21006 17935170 (Pubitemid 350006310)
35. Three-dimensional spheroid model in tumor biology. Santini MT, Rainaldi G, Pathobiology 1999 67 148 157 10.1159/000028065 10394136 (Pubitemid 29304376)
36. Virus isolation and quantitation. Hierholzer JC, Killington RA, Virology Methods Manual Glasgow: Academic press limited, Mahy BWJ, Kangro HO, 1996 25 46
37. Enteroviruses in Tunisia: virological surveillance over 12 years (1992-2003). Bahri O, Rezig D, Nejma-Oueslati BB, Yahia AB, Sassi JB, Hogga N, Sadraoui A, Triki H, J Med Microbiol 2005 54 63 69 10.1099/jmm.0.45695-0 15591257
38. Non-polio enteroviruses in acute flaccid paralysis children of India: vital assessment before polio eradication. Dhole TN, Ayyagari A, Chowdhary R, Shakya AK, Shrivastav N, Datta T, Prakash V, J Paediatr Child Health 2009 45 409 413 10.1111/j.1440-1754.2009.01529.x 19712176
39. Selective inhibitors of picornavirus replication. De Palma AM, Vliegen I, De Clercq E, Neyts J, Med Res Rev 2008 28 823 884 10.1002/med.20125 18381747
40. Treatment of potentially life-threatening enterovirus infections with pleconaril. Rotbart HA, Webster AD, Clin Infect Dis 2001 32 228 235 10.1086/318452 11170912 (Pubitemid 32524792)
41. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. McKee TD, Grandi P, Mok W, Alexandrakis G, Insin N, Zimmer JP, Bawendi MG, Boucher Y, Breakefield XO, Jain RK, Cancer Res 2006 66 2509 2513 10.1158/0008-5472.CAN-05-2242 16510565
42. Viruses as antitumor weapons: defining conditions for tumor remission. Wodarz D, Cancer Res 2001 61 3501 3507 11309314 (Pubitemid 32695047)
43. A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. Gullberg M, Tolf C, Jonsson N, Polacek C, Precechtelova J, Badurova M, Sojka M, Mohlin C, Israelsson S, Johansson K, Bopegamage S, Hafenstein S, Lindberg AM, J Virol 2010 84 5868 5879 10.1128/JVI.02383-09 20375176
44. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW, Proc Natl Acad Sci USA 1994 91 6245 6248 10.1073/pnas.91.13.6245 7517044 (Pubitemid 24188320)
45. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW, J Gen Virol 1998 79 Pt 7 1707 1713 9680134 (Pubitemid 28330675)
46. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD, J Virol 1997 71 4736 4743 9151867 (Pubitemid 27204166)
47. Differences in the capacity of reovirus strains to induce apoptosis aredetermined by the viral attachment protein sigma 1. Tyler KL, Squier MKT, Rodgers SE, Schneider BE, Oberhaus SM, Grdina TA, Cohen JJ, Dermondy, J Virol 1995 69 6972 6979 7474116
48. Variation in enterovirus receptor genes. Karttunen A, Pöyry T, Vaarala O, Ilonen J, Hovi T, Roivainen M, Hyypiä T, J Med Virol 2003 70 99 108 10.1002/jmv.10352 12629650 (Pubitemid 36368871)
49. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. Ward T, Pipkin PA, Clarkson NA, Stone DM, Minor PD, Almond JW, Embo J 1994 13 5070 5074 7525274
50. Decay-accelerating factor: biochemistry, molecular biology, and function. Lublin DM, Atkinson JP, Annu Rev Immunol 1989 7 35 58 10.1146/annurev.iy.07. 040189.000343 2469439 (Pubitemid 19138006)
51. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Koretz K, Bruderlein S, Henne C, Moller P, Br J Cancer 1992 66 810 814 10.1038/bjc.1992.365 1384641
52. Polymorphic expression of decay-accelerating factor in human colorectal cancer. Nakagawa M, Mizuno M, Kawada M, Uesu T, Nasu J, Takeuchi K, Okada H, Endo Y, Fujita T, Tsuji T, J Gastroenterol Hepatol 2001 16 184 189 10.1046/j.1440-1746.2001.02418.x 11207899 (Pubitemid 32226191)
53. Studies of Echovirus 5 interactions with the cell surface: heparan sulfate mediates attachment to the host cell. Israelsson S, Gullberg M, Jonsson N, Roivainen M, Edman K, Lindberg AM, Virus Res 2010 151 170 176 10.1016/j.virusres.2010.05.001 20466025